DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 214 filers reported holding DENALI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $242,155 | -15.9% | 11,738 | +20.3% | 0.01% | -9.1% |
Q2 2023 | $287,900 | +43.5% | 9,756 | +12.0% | 0.01% | +37.5% |
Q1 2023 | $200,655 | -22.4% | 8,709 | 0.0% | 0.01% | -20.0% |
Q4 2022 | $258,657 | +13.0% | 8,709 | +16.6% | 0.01% | 0.0% |
Q3 2022 | $229,000 | +4.6% | 7,469 | 0.0% | 0.01% | +11.1% |
Q2 2022 | $219,000 | -4.8% | 7,469 | +4.7% | 0.01% | +12.5% |
Q1 2022 | $230,000 | -27.7% | 7,134 | 0.0% | 0.01% | -27.3% |
Q4 2021 | $318,000 | -11.7% | 7,134 | 0.0% | 0.01% | -15.4% |
Q3 2021 | $360,000 | -35.7% | 7,134 | 0.0% | 0.01% | -35.0% |
Q2 2021 | $560,000 | +91.8% | 7,134 | +39.5% | 0.02% | +81.8% |
Q1 2021 | $292,000 | -33.8% | 5,115 | -2.9% | 0.01% | -45.0% |
Q4 2020 | $441,000 | +121.6% | 5,268 | -5.2% | 0.02% | +122.2% |
Q3 2020 | $199,000 | +48.5% | 5,555 | 0.0% | 0.01% | +50.0% |
Q2 2020 | $134,000 | +83.6% | 5,555 | +32.5% | 0.01% | +50.0% |
Q1 2020 | $73,000 | 0.0% | 4,193 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $73,000 | +28.1% | 4,193 | +13.2% | 0.00% | 0.0% |
Q3 2019 | $57,000 | -26.0% | 3,705 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $77,000 | -10.5% | 3,705 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $86,000 | +11.7% | 3,705 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $77,000 | -4.9% | 3,705 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $81,000 | +285.7% | 3,705 | +172.0% | 0.00% | +300.0% |
Q2 2018 | $21,000 | -22.2% | 1,362 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $27,000 | – | 1,362 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |